Physician profile
Ishan Singhal
NPI 1285328930
$2,057.54
in general payments reported to CMS, 2019-2025
13 companies · $1,033 in 2025
The $1,033 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $208 · 2024: $816 · 2025: $1,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,038 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,037.54 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $336.64 | 2023-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Depuy Synthes Sales INC. | $275.65 | 2024 | Synthecel, Matrixneuro |
| Stryker Corporation | $244.35 | 2024-2025 | Universal Neuro 3, Adherus Autospray Dural Sealant, Na |
| Kuros Biosciences USA, INC | $221.03 | 2024 | Magnetos |
| Kerecis Limited | $187.14 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Mimedx Group, INC. | $170.56 | 2025 | |
| Si-Bone, INC. | $155.50 | 2023 | |
| Augmedics INC. | $137.68 | 2024 | Xvision |
| Integra Lifesciences Corporation | $117.06 | 2025 | Codman Certas, Cusa Clarity, Codman Hakim |
| Aesculap, INC. | $92.37 | 2024 | M.Blue |
| Globus Medical, INC. | $70.67 | 2025 | Independence, Fortify, Continental |
| Baxter Healthcare | $28.89 | 2025 | Floseal |
| Csl Behring | $20.00 | 2024 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ishan Singhal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.